(Q37573399)

21 August 2017

1 reference

title

Alternative splicing and biological heterogeneity in prostate cancer (English)

1 reference

alternative mRNA splicing, via spliceosome

21 August 2017

main subject

1 reference

1 reference

1 reference

Prabhakar Rajan

1

1 reference

21 August 2017

David J Elliott

series ordinal

2

1 reference

21 August 2017

Craig N Robson

series ordinal

3

1 reference

21 August 2017

Hing Y Leung

series ordinal

4

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

21 August 2017

published in

Nature Reviews Urology

1 reference

21 August 2017

volume

6

1 reference

21 August 2017

issue

8

1 reference

21 August 2017

page(s)

454-460

1 reference

https://scigraph.springernature.com/pub.10.1038/nrurol.2009.125

21 August 2017

exact match

0 references

cites work

EAU guidelines on prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Prostate cancer: estimating the benefits of PSA screening

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Prostate cancer genomics: towards a new understanding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Why do humans have so few genes?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Function of alternative splicing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Aberrant and alternative splicing in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

31 March 2020

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

ETS gene fusions in prostate cancer: from discovery to daily clinical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

FGF8 isoform b expression in human prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Alternative splicing: an emerging topic in molecular and clinical oncology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

The connection between splicing and cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

A Germline DNA Polymorphism Enhances Alternative Splicing of theKLF6Tumor Suppressor Gene and Is Associated with Increased Prostate Cancer Risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Splicing in disease: disruption of the splicing code and the decoding machinery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

The emerging role of splicing factors in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

The gene encoding the splicing factor SF2/ASF is a proto-oncogene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

CLIP: a method for identifying protein-RNA interaction sites in living cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

From signatures to models: understanding cancer using microarrays

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Two-dimensional transcriptome profiling: identification of messenger RNA isoform signatures in prostate cancer from archived paraffin-embedded cancer specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Profiling alternatively spliced mRNA isoforms for prostate cancer classification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Next-generation DNA sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Determination of tag density required for digital transcriptome analysis: application to an androgen-sensitive prostate cancer model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Splice variants as cancer biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Complex alternative splicing of the hKLK3 gene coding for the tumor marker PSA (prostate-specific-antigen).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

CD44: from adhesion molecules to signalling regulators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Manipulation of alternative splicing by a newly developed inhibitor of Clks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Alternative splicing in cancer: noise, functional, or systematic?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Multiple newly identified loci associated with prostate cancer susceptibility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Mechanisms of alternative pre-messenger RNA splicing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Understanding alternative splicing: towards a cellular code

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

Signal-dependent regulation of splicing via phosphorylation of Sam68

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.125

31 March 2020

Identifiers

DOI

10.1038/NRUROL.2009.125

1 reference

Dimensions Publication ID

21 August 2017

1002872513

0 references

1 reference